BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37230955)

  • 1. Plasma arginine metabolites in health and chronic kidney disease.
    Au AYM; Mantik K; Bahadory F; Stathakis P; Guiney H; Erlich J; Walker R; Poulton R; Horvath AR; Endre ZH
    Nephrol Dial Transplant; 2023 Nov; 38(12):2767-2775. PubMed ID: 37230955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
    J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Sapa H; Gutiérrez OM; Shlipak MG; Katz R; Ix JH; Sarnak MJ; Cushman M; Rhee EP; Kimmel PL; Vasan RS; Schrauben SJ; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
    Am J Kidney Dis; 2022 Oct; 80(4):502-512.e1. PubMed ID: 35351578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
    Krzystek-Korpacka M; Wiśniewski J; Fleszar MG; Bednarz-Misa I; Bronowicka-Szydełko A; Gacka M; Masłowski L; Kędzior K; Witkiewicz W; Gamian A
    Oxid Med Cell Longev; 2019; 2019():5965721. PubMed ID: 31396302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German Chronic Kidney Disease cohort.
    Maas R; Mieth M; Titze SI; Hübner S; Fromm MF; Kielstein JT; Schmid M; Köttgen A; Kronenberg F; Krane V; Hausknecht B; Eckardt KU; Schneider MP
    Nephrol Dial Transplant; 2020 Jul; 35(7):1187-1195. PubMed ID: 30476224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
    Brooks ER; Langman CB; Wang S; Price HE; Hodges AL; Darling L; Yang AZ; Smith FA
    Pediatr Nephrol; 2009 Jan; 24(1):129-34. PubMed ID: 18830716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Schrauben SJ; Sapa H; Xie D; Zhang X; Anderson AH; Shlipak MG; Hsu CY; Shafi T; Mehta R; Bhat Z; Brown J; Charleston J; Chen J; He J; Ix JH; Rao P; Townsend R; Kimmel PL; Vasan RS; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
    Nephrol Dial Transplant; 2023 Nov; 38(12):2809-2815. PubMed ID: 37230949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
    Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
    PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry.
    Wang S; Vicente FB; Miller A; Brooks ER; Price HE; Smith FA
    Clin Chem Lab Med; 2007; 45(10):1305-12. PubMed ID: 17663630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of the L-Arginine/Dimethylarginine/Nitric Oxide Pathway in People with Chronic Airflow Obstruction and Obstructive Sleep Apnoea.
    Hannemann J; Thorarinnsdottir EH; Amaral AFS; Schwedhelm E; Schmidt-Hutten L; Stang H; Benediktsdottir B; Gunnarsdóttir I; Gislason T; Böger R
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
    Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
    Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
    Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.
    Szlęzak D; Ufnal M; Drapała A; Samborowska E; Wróbel M
    Amino Acids; 2023 Apr; 55(4):529-539. PubMed ID: 36802034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Di Gangi IM; Chiandetti L; Gucciardi A; Moret V; Naturale M; Giordano G
    Anal Chim Acta; 2010 Sep; 677(2):140-8. PubMed ID: 20837180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between endogenous dimethylarginines and renal function in healthy children and adolescents.
    Jaźwińska-Kozuba A; Martens-Lobenhoffer J; Surdacki A; Kruszelnicka O; Rycaj J; Godula-Stuglik U; Bode-Böger SM
    Int J Mol Sci; 2012 Nov; 13(11):15464-74. PubMed ID: 23203136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.